Allogenic stem cell transplantation
RecruitingStudy on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Study on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- Disease:Allogenic stem cell transplantation
- Substances:GSKVx000000017064RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A+1
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:GSKVx000000017064
- Sponsor:CHU De Liege










